Researchers are excited about the medication , a novel dual compound showing significant results in initial trials for weight reduction . It acts by modulating two pathways : GLP-1 and GIP, these, when stimulated, support influence cravings and boost energy expenditure . Early observations indicate considerable body management and possible advantag